top of page

PROTECTING  INTELLECTUAL PROPERTY.

PROTECTING  EMERGING TECHNOLOGIES.

SERVICES

SERVICES

UTILITY, DESIGN & PLANT
PATENT PROSECUTION
PATENT LITIGATION

& ENFORCEMENT

PATENT PORTFOLIO
DEVELOPMENT & STRATEGY
FREEDOM-TO-OPERATE OPINIONS
TECHNOLOGY, COMPETITOR
& LANDSCAPE REVIEWS
IP AUDITS
& DUE DILIGENCE
INTELLECTUAL PROPERTY AGREEMENTS & LICENSING
TRADEMARK, COPYRIGHT 
& OTHER IP SERVICES

DATA PRIVACY, TELEHEALTH & DIGITAL HEALTH ISSUES
REGULATORY APPROVAL & COMPLIANCE

VISION

Our vision is to provide unparalleled legal guidance to businesses by helping to generate value and growth through patents and intellectual property.

While a flower is budding, it is protected by a whorl of sepals that enclose the flower as it emerges and provide stability as it opens. This structure is the calyx. Like a calyx, we see our role as helping to ensure that seed stage and early stage companies have the protection and support they need to come into full bloom.

As practitioners, our goal is to be the foremost experts and most sought-out advocates on patent and IP issues central to emerging cutting-edge technologies. Founded in 2016, we were the first patent law boutique in California to focus on the cannabis industry, and we were among the first patent professionals anywhere to work on psychedelics.

VISION
ATTORNEYS
361E4EDC-6FFC-4874-B62D-9E06D5DFE848.jpeg

PAIGE

Operations Advisor

A former research associate and project manager with several years of experience supporting a variety of clinical trials, a B.S. in Biochemistry and a minor in Psychology, and a profound interest in utilizing cannabis and psychedelics to treat mental health, Paige oversees work across all aspects and functions of Calyx Law as Operations Advisor.

Open folder Calyx Ops Docs.png

GREG

Patent Agent

A registered patent agent with a degree in Chemistry, Greg brings his research experience in synthetic chemistry to his work at Calyx Law. Greg's patent practice has focused on drafting and prosecuting domestic and international patent applications, performing due diligence and freedom-to-operate analyses, and supporting litigation proceedings.

Screen Shot 2023-03-16 at 11.54.24 AM.png

BEN

Patent Paralegal / Ops Lead

Pursuing a Master’s degree in Psychoactive Pharmaceutical Investigation at the University of Wisconsin-Madison School of Pharmacy, with a degree in History and Political Science, Ben is a Research Assistant at Calyx Law. Ben is experienced in archival research, and his interests include patent analysis and the sourcing of prior art.

PATRICK bio pic - WEBSITE.jpg

PATRICK

Research Associate

A University of Minnesota Law School M.S. Patent Law graduate, UMN Technology Commercialization intern, and Johns Hopkins University M.S. Biotechnology student with the passion to explore the psychedelic patent space, Patrick brings his scientific and patent knowledge to Calyx Law to assist with prior art searches, due diligence, and patent drafting.

Headshot.jpg

TYLER

Research Assistant

Tyler is a Ph.D. candidate at Arizona State University and author of The Tab psychedelic science newsletter. Tyler combines his scientific research and communication skills with his passion for developing emerging biotechnologies as a Research Assistant at Calyx Law.

andrew headshot.jpg

ANDREW

Research Associate

Andrew Ferns is a student at Western Oregon University obtaining his B.S. in Medicinal Chemistry & Pharmacology with plans to pursue a Master’s in Medicinal Chemistry. Andrew brings his unique background in psychedelic chemistry to his position as a Chemistry Research Associate to Calyx Law. Andrew is also an amateur mycologist and designs small-scale automated mushroom cultivation systems.

Bio Pic.jpg

EMMA

Research Associate

A writer with expertise in scholarly research and education, especially relating to cannabis and psychedelic medicine, Emma is a Research Associate at Calyx Law. Emma has contributed work to leading platforms and publications in the cannabis and psychedelics spaces, and has written educational content for doctors and biotechnology companies.

Pechenik-Headshot.jpeg

GRAHAM

Founder / Patent Attorney

A registered patent attorney, with degrees in Biochemistry and Cognitive Neuroscience, Graham spent a decade representing Fortune 500 companies on their most critical patent matters, before founding Calyx Law to help cannabis and psychedelics ventures design and implement their patent and intellectual property strategies.

IMG_0038 Copy.JPG

CHRIS

Patent Attorney

A registered patent attorney, with a degree in Physics and a Master’s degree in Religion, Ethics, & Politics, Chris has worked at the intersection of intellectual property, international trade, and public policy for Fortune 500 companies and non-profit organizations for over 15 years, focusing on patent litigation, licensing, and IP commoning. 

photo_2023-05-20_15-14-46_edited.jpg

KODY

Research Intern

Kody graduated from the University of Minnesota with a background in neuroimaging and has spearheaded efforts for psychedelic legal reform in Washington State. He started a Master's degree in Pharmaceutical Sciences at the University of Wisconsin in 2022. Kody's work with Calyx Law stems from a strong belief that investment in psychedelic biotechnology can bring relief to millions suffering from mental health disorders.

Screen Shot 2023-05-23 at 7_edited.jpg

RACHEL

Legal Intern

Rachel is a J.D. candidate at the University of Wisconsin and has a B.S. in neuroscience from the University of Michigan. Rachel is passionate about the future of psychedelics and wants to combine this passion with her career in law. She is also the founder and executive director of a registered non-profit in Michigan called Carefree Capping. 

MEDIA

MEDIA

UPCOMING:

Psychedelics are a step away from becoming prescription medicines. Companies are flooding in to capitalize on what could become a $100B market, backed by a massive onrush of investment, and accompanied by a deluge of patent filings. With innovation in mental healthcare stagnant for decades, and the need for new therapies more urgent than ever, surely turning psychedelics into patented pharmaceuticals will be a force for good? Or will it instead entrench existing inequalities, and lead to immense profit for a few, while stifling further innovation and leaving the neediest patients unable to access important and lifesaving treatments?


Will the mainstreaming of psychedelics simply repeat old mistakes, or will it be an opportunity to reimagine—and psychedelicize—the medicines system itself?


ALL MEDIA >

Five Psychedelic Law Firms You Should Have On Your Radar

10-2-2-2048x1152.png
Screen Shot 2020-11-15 at 11.39.16 PM.pn
Screen Shot 2022-03-30 at 10.37.58 AM.png

Legalization and Decriminalization Tracker

Psychedelic Alpha Trackers

bottom of page